Nacuity Pharmaceuticals, Inc.
PrivateLast Round
Series B
Jun 15, 2022
Total Funding Raised
$38.73M
Momentum Score
25 /100
Company Overview
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that develops treatments for diseases caused by oxidative stress, such as retinitis pigmentosa and cataracts.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nacuity Pharmaceuticals, Inc. Comps
Public and private peers based on sector, stage, and business model.
Nacuity Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 15, 2022 | ||||
| Series A Extension | Jan 3, 2022 | ||||
| Series A | Jan 24, 2019 | ||||
| Seed | Nov 22, 2016 |
Nacuity Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Retinal Degeneration Fund | Series A, Series B |
| Johns Hopkins Technology Ventures | Series A |
| Tarnagulla Ventures | Series A |
| Foundation Fighting Blindness | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2025
Received designation for investigational therapy NPI-001 tablets.
Nacuity Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nacuity Pharmaceuticals, Inc.'s valuation, stock price, and market status.
